News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Praveen Kumar Marimuthu: Five-year overall survival update from the HIMALAYA study
Praveen Kumar Marimuthu/X
Apr 14, 2025, 14:22

Praveen Kumar Marimuthu: Five-year overall survival update from the HIMALAYA study

Praveen Kumar Marimuthu, DM Resident in Medical Oncology at Christian Medical College and Hospital, shared a post on X:

“Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC.”

Praveen Kumar Marimuthu: Five-year overall survival update from the HIMALAYA study

Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC

Authors: Lorenza Rimassa, et al.

Praveen Kumar Marimuthu: Five-year overall survival update from the HIMALAYA study

cancer Christian Medical College and Hospital Durvalumab fight against cancer Global fight against cancer HCC HIMALAYA study MedOnc OncoDaily Oncology Praveen Kumar Marimuthu Tremelimumab
Special Coverage
Blog
Apr 15, 2025, 07:52
Basel Refky: Presenting in Lebanon, Masterclass in Cairo, and a Publication — A Tough Weekend but Fruitful
Blog
Apr 15, 2025, 07:52
Luchuo Engelbert Bain: The Future is bright - African medical students taking their future into their hands
Blog
Apr 15, 2025, 07:40
Estela Rodriguez: The second-line options for EGFR lung cancer beyond platinum-chemo after best therapies upfront
Blog
Apr 15, 2025, 07:23
EACR about their affiliated journal, Molecular Oncology
Blog
Apr 15, 2025, 07:21
Enrolling for the ComboMATCH Treatment Trial E5 - ECOG-ACRIN Cancer Research Group
Opinion
Apr 15, 2025, 07:10
The NCCN 2025 Breast Cancer Congress recorded presentations are now available
Blog
Apr 15, 2025, 07:09
Roberto Ferrara: Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC
Blog
Apr 15, 2025, 07:04
Imane Bensalim: Honored to have participated in Sim Africa 2025
Blog
Apr 15, 2025, 06:40
The application for the 2025 Ambassador Program is open - American Society of Hematology
Blog
Apr 15, 2025, 06:16
Applications for the ENYGO Introduction to Robotic Surgery Course close May 12 - ESGO
Blog
Apr 15, 2025, 05:15
Don't miss the NCI Rising Scholars Cancer Research Seminar Series featuring Dr. Juan C. Osorio - Train at NCI
Blog
Apr 15, 2025, 04:10
Sally Wolf: 7 years with Stage IV cancer